In the latest edition of Target Research (issue 4 of 4, 2013) you'll read about our new research projects, which have all been assessed through our vigorous peer review system to ensure that we continue to fund only world-class scientific research. The projects focus on Duchenne muscular dystrophy and will investigate several different ways to develop new potential treatments.
We also take a look at biomarkers, and how researchers and clinicians are working to find safe, easy and non-invasive ways to assess muscle damage and monitor disease progression. These will be important in future clinical trials as they will help clinicians to measure the effectiveness of trial treatments.